Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction

International Journal of Cardiology

Volumn 115, Issue 1, 2007, Pages 42-45

  Patel, Jeetesh V ^a   Lee, Kaeng W ^a   Tomson, Joseph ^a   Dubb, Kiran ^a   Hughes, Elizabeth A ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Adipocytokines; Adiponectin; Insulin; Leptin; TNF

Indexed keywords

ADIPONECTIN; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HOMEOSTASIS; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; ENERGY METABOLISM; FATTY ACIDS, OMEGA-3; HOMEOSTASIS; HORMONES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS;

EID: 33845247319     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.04.004     Document Type: Article

References (14)

1. GISSI-Prevention Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevention trial. Lancet 354 (1999) 447-455
2. Bhatnagar D., and Durrington P.N. Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications. Int J Clin Pract 57 (2003) 305-314
3. Sirtori C.R., Paoletti R., Mancini M., et al. N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter Study. Am J Clin Nutr 65 6 (1997 (Jun)) 1874-1881
4. Toft I., Bonaa K.H., Ingebretsen O.C., Nordoy A., and Jenssen T. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med 123 (1995) 911-918
5. Oliver M.F., and Opie L.H. Effects of glucose and fatty acids on myocardial ischemia and arrhythmias. Lancet 343 (1994) 155-158
6. Niswender K.D., Baskin D.G., and Schwartz M.W. Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends Endocrinol Metab 15 (2004) 362-369
7. Rewers M., Zaccaro D., D'Agostino R., et al. Insulin resistance atherosclerosis study investigators. Insulin sensitivity, insulinemia, and coronary artery disease: the insulin resistance atherosclerosis study. Diabetes Care 27 (2004) 781-787
8. Ciccone M., Vettor R., Pannacciulli N., et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 25 (2001) 805-810
9. Jovinge S., Hamsten A., Tornvall P., et al. Evidence for a role of tumor necrosis factor α in disturbances of triglycerides and glucose metabolism predisposing to coronary heart disease. Metabolism 47 (1998) 113-118
10. Chan D.C., Watts G.F., Ng T.W., et al. Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin Chem 51 (2005) 578-585
11. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., and Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101 (2000) 2149-2153
12. Nakamura Y., Shimada K., Fukuda D., et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 90 (2004) 528-533
13. Saad M.F., Damani S., Gingerich R.L., et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 82 (1997) 579-584
14. McNulty P.H. Comparison of local and systemic effects of insulin on myocardial glucose extraction in ischemic heart disease. Am J Physiol Heart Circ Physiol 278 (2000) H741-H747